Indeed, treatment of an MS mouse model of experimental autoimmune encephalomyelitis (EAE) with 2-chloroacetamidine (2-CA), a PAD2 and PAD4 inhibitor, leads to disease attenuation (Moscarello et al., 2013). The gene discussed is PADI2; the disease is myeloid sarcoma.